Hinge Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Hinge Health (HNGE).

Price Target Range — 7 Quarters

Analyst Consensus — 18 Analysts

2S.Buy

15Buy

1Hold

Consensus RatingBuy# Analysts18Avg. Consensus PT$115Upside to Avg. PT-5.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 3, 2026	Freedom Capital Markets	Gene Mannheimer	PT Raise	Buy	$103→$135
Nov 3, 2026	Morgan Stanley	Craig Hettenbach	PT Raise	Overweight	$117→$131
Nov 3, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$112→$145
Nov 3, 2026	Wells Fargo	Stan Berenshteyn	PT Raise	Overweight	$103→$132
Nov 3, 2026	RBC Capital	Rishi Jaluria	PT Raise	Outperform	$110→$135
Nov 3, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$125→$150
Nov 3, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$105→$134
Nov 3, 2026	Stifel	David Grossman	PT Raise	Buy	$130→$135
Nov 3, 2026	Needham	Ryan MacDonald	PT Raise	Buy	$115→$135
Oct 26, 2026	Stifel	David Grossman	PT Raise	Buy	$115→$130
Oct 16, 2026	Keybanc	Scott Schoenhaus	PT Raise	Overweight	$125→$140
Oct 12, 2026	Barclays	Saket Kalia	PT Raise	Overweight	$100→$110
Sep 30, 2026	Needham	Ryan MacDonald	PT Raise	Buy	$97→$115
Sep 22, 2026	Baird	Vikram Kesavabhotla	PT Raise	Neutral	$85→$90
Sep 8, 2026	Stifel	David Grossman	PT Raise	Buy	$96→$115
Aug 11, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$85→$112
Aug 5, 2026	RBC Capital	Rishi Jaluria	PT Raise	Outperform	$75→$110
Aug 5, 2026	Citizens	Aaron Kimson	PT Raise	Market Outperform	$96→$107
Aug 5, 2026	Wells Fargo	Stan Berenshteyn	PT Raise	Overweight	$90→$103
Aug 5, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$100→$105

Analyst Ratings News

PRO
Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

Freedom Capital Markets analyst Gene Mannheimer maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $103 to $135.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $117 to $131.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $112 to $145.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $103 to $132.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $110 to $135.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $125 to $150.

Benzinga Newsdesk

Hinge Health Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Hinge Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

PRO
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

PRO
Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

PRO
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

PRO
RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

PRO
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150

People Also Watch

People Also Watch

Hinge Health Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Hinge Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROFreedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

PROMorgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

PROTruist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

PROWells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

PRORBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

PROEvercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150

People Also Watch

People Also Watch

PRO
Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

PRO
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

PRO
Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

PRO
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

PRO
RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

PRO
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150